APVO - Aptevo Therapeutics Inc
IEX Last Trade
0.35
-0.004 -1.086%
Share volume: 170,555
Last Updated: Fri 30 Aug 2024 08:21:25 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.35
0.00
-1.07%
Summary score
10%
Profitability
0%
Dept financing
13%
Liquidity
45%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-43.25%
Return on assets
-16.93%
Return on sales
-200.05%
Return on invested capital
-539.45%
Total debt ratio
46.23%
Debt ratio change over timeo
-1.12%
Current Ratio
3.67%
Quick Ratio
3.65%
Cash Position Ratio
1.39%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-70.79%
Return on assets
-24.71%
Return on sales
-101.23%
Return on invested capital
-216.06%
Total debt ratio
59.62%
Debt ratio change over timeo
-0.69%
Current Ratio
1.35%
Quick Ratio
0.71%
Cash Position Ratio
0.98%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-78.65%
Return on assets
-36.78%
Return on sales
0%
Return on invested capital
-667.62%
Total debt ratio
53.27%
Debt ratio change over time
-1.16%
Current Ratio
1.5%
Quick Ratio
0%
Cash Position Ratio
1.35%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-71.81%
Return on assets
-95.55%
Return on sales
-1.67%
Return on invested capital
381.1%
Total debt ratio
-112.17%
Debt ratio change over time
-1.12%
Current Ratio
-3.36%
Quick Ratio
-3.59%
Cash Position Ratio
-1.53%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | APVO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -43.25% | -3.05% | 11.55% | 6.27% |
| Return on assets | -16.93% | 3.6% | 3.57% | 5.27% |
| Return on sales | -200.05% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -539.45% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 46.23% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.12% | 6.09% | 6.03% | 1.53% |
| Dept financing | 11% | 50% | 43% | 14% |
| Current Ratio | 1.35% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0.71% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.98% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 33% | 58% | 69% |
| Short-term ratios | APVO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -70.79% | -25.62% | 17.94% | 7.14% |
| Return on assets | -24.71% | 3.26% | 3.67% | 4.71% |
| Return on sales | -101.23% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -216.06% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 59.62% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.69% | -23.44% | 9.66% | 0.6% |
| Dept financing | 14% | 25% | 45% | 8% |
| Current Ratio | 1.35% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0.71% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.98% | 1.48% | 0.76% | 1.49% |
| Liquididy | 32% | 57% | 42% | 75% |